New vaccine for HIV patients
image courtesy of bitzi / Flickr
Scientists have announced a new vaccine, still in trial, which could allow HIV/AIDS patients a hiatus from their normal and difficult daily drug regimen. It is not a cure, but it does alter and maybe make more easy the traditional treatments.
"The Takeaway" talks to Dr. Barry Peters, an AIDS researcher at King’s College in London, about the vaccine.
Dr. Peters says, "It’s a fairly new concept — its a theraputic vaccine. In other words, it’s a vaccine that is given to someone who has the disease, in this case, HIV, in order to boost the immune system. Drugs work completely differently; they simply block the virus and do not help the immune system.
The idea of this vaccine, which I stress is still in the testing phase, is to boost the body’s natural immune system."
This immune system boost could conceivably prevent someone who is HIV positive from contracting the full-blown AIDS virus.
"The Takeaway" is PRI’s new national morning news program, delivering the news and analysis you need to catch up, start your day, and prepare for what’s ahead. The show is a co-production of WNYC and PRI, in editorial collaboration with the BBC, The New York Times Radio, and WGBH.
More at thetakeaway.org
The story you just read is available to read for free because thousands of listeners and readers like you generously support our nonprofit newsroom. Every day, the reporters and producers at The World are hard at work bringing you human-centered news from across the globe. But we can’t do it without you: We need your support to ensure we can continue this work for another year.
When you make a gift of $10 or more a month, we’ll invite you to a virtual behind-the-scenes tour of our newsroom to thank you for being with The World.